Skye Bioscience, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Skye Bioscience, Inc. (SKYE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $6.59 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-10
- Skye Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $6.59M, a 414.13% increase from fiscal 2024.
- Skye Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.28M, a 94.30% decline from fiscal 2023.
- Skye Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $22.50M, a 34.93% decline from fiscal 2022.
- Skye Bioscience, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $34.58M, a 1839.25% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $6.59M 10-K · filed 2026-03-10 |
| 2024-12-31 | $1.28M 10-K · filed 2025-03-20 |
| 2023-12-31 | $22.50M 10-K · filed 2024-03-22 |
| 2022-12-31 | $34.58M 10-K · filed 2023-03-31 |
| 2021-12-31 | $1.78M 10-K · filed 2022-03-28 |
| 2020-12-31 | $1.38M 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |